Corcept Therapeutics Incorporated

CORT·NasdaqCM·Healthcare
Compare
79.22−2.71 (−3.31%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close81.93
Open84.98
Day range71.2984.98
52-week range28.66126.38
Off day high−6.78%
Off 52-week high−37.32%
Volume2.12M
Avg. volume (3M)1.17M
Market cap8.56B
EPS (TTM)1.33
Forward P/E18.77
P/E ratio (TTM)59.56
Dividend yield—
Beta (5Y)0.40
Shares outstanding108.10M
Short interest10.24% of float
Earnings dateNov 3, 2026
Analyst target141.00
Profit margin6.64%

Against its peers

Compare in full ›
CORT RYTM ROIV ACAD VKTX MIRM
Market cap 8.56B 7.67B 27.61B 3.70B 3.57B 6.30B
P/E (TTM) 59.6 — — 9.6 — —
Forward P/E 18.8 -170.1 -27.5 23.3 -5.5 -570.4
Price/book 10.4 87.2 6.5 3.0 6.1 16.0
Dividend yield — — — — — —
1-year change +6.89% −13.10% +78.15% −7.88% −28.46% +24.17%
Today −3.31% +28.04% +6.08% +4.38% +7.21% +11.42%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All CORT news ›
Seeking Alpha·Negative

Corcept Therapeutics plunges 20% on Genmab cancer data

Shares of Corcept Therapeutics ( CORT ), a commercial-stage biopharmaceutical company focused on cortisol modulation, sank 20% on Friday. The stock dropped $21.64 to end at $85.86 with volume of ... SA Spotlight uses AI to summarize…

Stock Titan·

Corcept Therapeutics officer sells 8,333 shares

Corcept Therapeutics Inc. (CORT) is a commercial-stage pharmaceutical company focused on cortisol modulation for hypercortisolism, oncology, ALS and liver disease. - [Form 4] CORCEPT THERAPEUTICS INC Insider Trading Activity Corcept…

Stock Titan·

Corcept Therapeutics' Lyon sells 4,744 shares

Corcept Therapeutics Inc. (CORT) is a commercial-stage pharmaceutical company focused on cortisol modulation for hypercortisolism, oncology, ALS and liver disease. - [Form 4] CORCEPT THERAPEUTICS INC Insider Trading Activity Corcept…

From the 4Search news index, newest first.

In the news

17mentions in 30 days
13with it in the headline
Mixedsentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 17 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance